Encompass Health reports Q4 and FY2024 earnings; detailed results not extractable from provided exhibits

Encompass Health Corp

2024-FY EPS reported $4.46 revenue$5,373,200,000

Earnings press release (Ex 99.1) and supplemental slides (Ex 99.2) referenced but not included in filing text.
Filing body discusses non-GAAP measures and forward-looking statements; no specific revenue or EPS figures available.
Company filed 8-K on Feb 6, 2025 for results for three months and year ended December 31, 2024.
Non-GAAP metrics described (adjusted EPS, EBITDA, free cash flow) with reconciliations in missing exhibits.
Earnings call scheduled for Feb 7, 2025; supplemental slides to be used.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.